Plain-English translation of NCT07452562 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Sclerosis research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether hesperidin—a natural compound found in citrus fruits like oranges and lemons—can help reduce fatigue, improve mood, and support clearer thinking in people with MS. In animal studies, hesperidin showed promise in reducing inflammation and oxidative stress, which are thought to contribute to MS symptoms. This trial will give some participants the medication and others a placebo (a pill with no active ingredient) to see if the treatment actually works in people.
While there are disease-modifying treatments for MS, many people still struggle with debilitating fatigue and cognitive problems that affect daily life. This medication may offer a simple, low-risk option to manage these difficult symptoms alongside standard MS treatments, but it needs to be tested properly in people first.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to take either hesperidin capsules or matching placebo capsules once daily for 12 weeks. The study is conducted remotely, so you won't need to visit a clinic. You'll complete questionnaires about your fatigue, mood, and thinking at the start and end of the 12 weeks to measure any changes. Researchers will also ask about your diet and any MS symptoms you experience during the study.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United Kingdom
Sponsor
Swansea University
Collaborators
BioActor B.V.
Enrollment target
~60 participants
Started
January 2026
Primary completion
January 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Hayley Young, PhD
Swansea University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.